[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 0:**  The drug Cefepime (RxCUI 20481), also known as Cefepime Hydrochloride and sold under the brand name Maxipime, is indicated for treating Pneumonia (UMLS:C0032285), Osteomyelitis (UMLS:C0029443), and Urinary tract infection (UMLS:C0042029), corresponding to MONDO:0005249, MONDO:0005246, and MONDO:0005247 respectively.  This indicates Cefepime's use in treating bacterial infections across various systems.\n\n**Row 1:** The drug Ketotifen (RxCUI 6146), marketed as Alaway and Zaditor, is indicated for treating Hypersensitivity (UMLS:C0020517), which maps to MONDO:0005271. This suggests Ketotifen is an antihistamine or medication targeting allergic reactions.\n\n**Row 2:** Budesonide Nasal Spray (RxCUI 19831), with brand names like Entocort, Pulmicort, Rhinocort, and Uceris, treats various inflammatory bowel conditions including Ulcerative Colitis (UMLS:C0009324), Crohn's disease (UMLS:C0010346), Microscopic Colitis (UMLS:C0400821), and Colitis (UMLS:C0009319), corresponding to MONDO:0005101, MONDO:0005011, MONDO:0000702, and MONDO:0005292 respectively. This highlights its role in managing inflammatory bowel diseases.\n\n**Row 3:** Oseltamivir (RxCUI 260101), also known as Oseltamivir Phosphate and Tamiflu, is indicated for Influenza (UMLS:C0021400) and H1N1 influenza (UMLS:C2076600), which map to MONDO:0013855 and MONDO:0005460 respectively. This shows Oseltamivir's antiviral properties specifically targeting influenza viruses.\n\n**Row 4:** Cefpodoxime (RxCUI 20489), including Cefpodoxime Proxetil, has no indications listed in the provided data.  This suggests missing or incomplete information for this drug."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 1:**\n\n1. **Column Names and Values:** `drug_labels: ETHAMBUTOL|ETHAMBUTOL HYDROCHLORIDE|ETHAMBUTOL HYDROCHLORIDE; drug_rxcui: 4110; indications_label: Tuberculosis|Pulmonary tuberculosis|Mycobacterium avium complex infection; indications_mondo: MONDO:0018076|MONDO:0006052|MONDO:0005866; indications_umls: C0041296|C0041327|C0026916`\n\n2. **Descriptive Sentence:** The drug Ethambutol (RxCUI 4110) is indicated for the treatment of tuberculosis, including pulmonary tuberculosis and Mycobacterium avium complex infection, as represented by the MONDO and UMLS codes.\n\n3. **Summary Statement:** Ethambutol is an anti-tuberculosis medication targeting various forms of the disease.\n\n\n**Row 2:**\n\n1. **Column Names and Values:** `drug_labels: INFLECTRA|INFLIXIMAB|INFLIXIMAB-DYYB|REMICADE; drug_rxcui: 191831; indications_label: Crohn's disease|Colitis ulcerative|Rheumatoid arthritis|Ankylosing spondylitis|Psoriatic arthropathy|Inflammatory bowel disease|Psoriasis|Colitis|Behcet's syndrome|Hidradenitis|Sarcoidosis|Juvenile idiopathic arthritis|Arthritis|Uveitis|Spondylitis|Pyoderma gangrenosum|Spondyloarthropathy|Kawasaki's disease|Takayasu's arteritis|Gastrointestinal disorder|Polyarthritis|Irritable bowel syndrome; indications_mondo: MONDO:0005011|MONDO:0005101|MONDO:0008383|MONDO:0005306|MONDO:0011849|MONDO:0005265|MONDO:0005083|MONDO:0005292|MONDO:0007191|MONDO:0002260|MONDO:0019338|MONDO:0011429|MONDO:0005578|MONDO:0020283|MONDO:0003937|MONDO:0018824|MONDO:0005095|MONDO:0012727|MONDO:0017991|MONDO:0004335|MONDO:0024280|MONDO:0005052; indications_umls: C0010346|C0009324|C0003873|C0038013|C0003872|C0021390|C0033860|C0009319|C0004943|C0085160|C0036202|C3495559|C0003864|C0042164|C0038012|C0085652|C0949691|C0026691|C0039263|C0017178|C0162323|C0022104`\n\n2. **Descriptive Sentence:** Infliximab (RxCUI 191831), sold under brand names like Remicade and Inflectra, treats a wide range of inflammatory conditions including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and many others,  as indicated by numerous MONDO and UMLS codes.\n\n3. **Summary Statement:** Infliximab is a broad-spectrum biologic agent used to treat various autoimmune and inflammatory diseases.\n\n\n**Row 3:**\n\n1. **Column Names and Values:** `drug_labels: Leukine|SARGRAMOSTIM; drug_rxcui: 69634; indications_label: Malignant melanoma; indications_mondo: MONDO:0005105; indications_umls: C0025202`\n\n2. **Descriptive Sentence:** Sargramostim (RxCUI 69634), also known as Leukine, is used in the treatment of malignant melanoma, as specified by its MONDO and UMLS codes.\n\n3. **Summary Statement:** Sargramostim is a medication used in the treatment of a specific type of cancer, malignant melanoma.\n\n\n**Row 4:**\n\n1. **Column Names and Values:** `drug_labels: BUDESONIDE|BUDESONIDE.|BUDESONIDE/FORMOTEROL|Formoterol|SYMBICORT; drug_rxcui: 389132; indications_label: Chronic obstructive pulmonary disease|Asthma|Emphysema|Bronchitis|Lung disorder|Crohn's disease|Colitis microscopic|Bronchitis chronic|Respiratory disorder|Pneumonia|Colitis ulcerative; indications_mondo: MONDO:0011751|MONDO:0004979|MONDO:0004849|MONDO:0003781|MONDO:0005275|MONDO:0005011|MONDO:0000702|MONDO:0003781|MONDO:0005087|MONDO:0005249|MONDO:0005101; indications_umls: C0024117|C0004096|C0034067|C0006277|C0024115|C0010346|C0400821|C0008677|C0035204|C0032285|C0009324`\n\n2. **Descriptive Sentence:** Budesonide (RxCUI 389132), often combined with formoterol as in Symbicort, treats various respiratory conditions such as chronic obstructive pulmonary disease, asthma, and other lung disorders, as well as some inflammatory bowel diseases, according to its MONDO and UMLS codes.\n\n3. **Summary Statement:** Budesonide is a corticosteroid used to treat respiratory illnesses and, in some cases, inflammatory bowel disease.\n\n\n**Row 5:**\n\n1. **Column Names and Values:** `drug_labels: ERTAPENEM|ERTAPENEM SODIUM|ERTAPENEM.|INVANZ; drug_rxcui: 325642; indications_label: Urinary tract infection|Osteomyelitis; indications_mondo: MONDO:0005247|MONDO:0005246; indications_umls: C0042029|C0029443`\n\n2. **Descriptive Sentence:** Ertapenem (RxCUI 325642), marketed as Invanz, is an antibiotic indicated for the treatment of urinary tract infections and osteomyelitis, as defined by MONDO and UMLS classifications.\n\n3. **Summary Statement:** Ertapenem is a carbapenem antibiotic effective against bacterial infections in the urinary tract and bones."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 1: The drug Amifostine, with RXCUI 4126 and labels AMIFOSTINE, AMIFOSTINE., and ETHYOL, lacks specified indications in the provided label, Mondo, or UMLS fields.  This suggests that either the indications are not listed in this dataset or that further information is required to determine its therapeutic uses.\n\nRow 2:  Chloroquine, with RXCUI 2393 and labels CHLOROQUINE, CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE., and CHLOROQUINE., is indicated for systemic lupus erythematosus, as identified by the label, MONDO ID 0007915, and UMLS C0024141. This row shows a clear indication for a specific autoimmune disease.\n\nRow 3: Fibrinogen, marketed as RIASTAP and with RXCUI 831503, lacks specified indications in the provided label, Mondo, or UMLS fields.  Similar to Row 1, the absence of indications suggests incomplete data or a need for additional information.\n\nRow 4:  The drugs Bonjesta, Diclegis, and Unisom, collectively identified by RXCUI 3642, have no indications listed in the label, Mondo, or UMLS fields, indicating missing information on their therapeutic uses.\n\nRow 5: Etodolac, with RXCUI 24605 and labels ETODOLAC, ETODOLAC., and Lodine, lacks specified indications in the provided label, Mondo, or UMLS fields. This is consistent with the pattern of missing indication data observed in several other rows."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 16:  The drug OLYSIO (SIMEPREVIR), with RxCUI 1482790, is indicated for the treatment of Hepatitis C and Hepatic cirrhosis, corresponding to MONDO:0005231 and MONDO:0005155, and UMLS C0019196 and C0023890 respectively.  This row shows a drug specifically indicated for liver conditions.\n\nRow 18: The drug LABETALOL (with variations LABETALOL HYDROCHLORIDE), having RxCUI 6185, is indicated for Hypertension, which maps to MONDO:0005044 and UMLS C0020538. This row indicates a drug used for treating high blood pressure.\n\nRow 19: The drug MESNA (with variations MESNA and MESNEX), with RxCUI 44, has no listed indications in the provided data.  This row suggests missing or incomplete information regarding the drug's indications.\n\nRow 17: The drug ETHOSUXIMIDE (with variations ETHOSUXIMIDE and Zarontin), having RxCUI 4135, is indicated for Epilepsy and Petit mal epilepsy, corresponding to MONDO:0005027 and MONDO:0010826, and UMLS C0014544 and C0014553 respectively. This row shows a drug used for treating specific types of epilepsy.\n\nRow 15: The drug CYTOTEC (MISOPROSTOL), with RxCUI 42331, has no listed indications in the provided data. This row, similar to row 19, indicates missing or incomplete information on the drug's indications."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 1:**\n\n1. **Column Names and Values:** `drug_labels`: OLANZAPINE|OLANZAPINE PAMOATE|OLANZAPINE.|ZYPREXA; `drug_rxcui`: 61381; `indications_label`: Schizophrenia|Bipolar disorder|Psychotic disorder|Depression|Schizoaffective disorder|Anxiety|Mental disorder|Schizophrenia, paranoid type|Sleep disorder|Affective disorder|Insomnia|Dementia|Obsessive-compulsive disorder|Anxiety disorder; `indications_mondo`: MONDO:0005090|MONDO:0004985|MONDO:0005485|MONDO:0002050|MONDO:0005487|MONDO:0011918|MONDO:0002025|MONDO:0001484|MONDO:0003406|MONDO:0005371|MONDO:0013600|MONDO:0001627|MONDO:0008114|MONDO:0005618; `indications_umls`: C0036341|C0005586|C0033975|C0011570|C0036337|C0003467|C0004936|C0036349|C0851578|C0525045|C0917801|C0497327|C0028768|C0003469\n\n2. **Sentence Description:** The drug Olanzapine (RXCUI 61381), also known as Zyprexa, is indicated for the treatment of a wide range of mental health disorders including schizophrenia, bipolar disorder, psychotic disorders, depression, and anxiety, as represented by numerous MONDO and UMLS codes.\n\n3. **Summary:** Olanzapine is a broadly indicated antipsychotic medication used to treat various mental health conditions.\n\n\n**Row 2:**\n\n1. **Column Names and Values:** `drug_labels`: ENTYVIO|Vedolizumab; `drug_rxcui`: 1538097; `indications_label`: Crohn's disease|Colitis ulcerative|Inflammatory bowel disease|Colitis|Graft versus host disease; `indications_mondo`: MONDO:0005011|MONDO:0005101|MONDO:0005265|MONDO:0005292|MONDO:0013730; `indications_umls`: C0010346|C0009324|C0021390|C0009319|C0018133\n\n2. **Sentence Description:** The drug Vedolizumab (RXCUI 1538097), marketed as Entyvio, treats inflammatory bowel diseases such as Crohn's disease, ulcerative colitis, and graft-versus-host disease, supported by corresponding MONDO and UMLS codes.\n\n3. **Summary:** Vedolizumab is a targeted therapy for inflammatory bowel diseases.\n\n\n**Row 3:**\n\n1. **Column Names and Values:** `drug_labels`: CARISOPRODOL|CARISOPRODOL.|SOMA; `drug_rxcui`: 2101; `indications_label`: ; `indications_mondo`: ; `indications_umls`: \n\n2. **Sentence Description:** Carisoprodol (RXCUI 2101), also known as Soma, has no listed indications in this dataset.\n\n3. **Summary:**  No indications are provided for Carisoprodol in this dataset.\n\n\n**Row 4:**\n\n1. **Column Names and Values:** `drug_labels`: Edoxaban|SAVAYSA; `drug_rxcui`: 1599538; `indications_label`: Atrial fibrillation|Pulmonary embolism; `indications_mondo`: MONDO:0004981|MONDO:0005279; `indications_umls`: C0004238|C0034065\n\n2. **Sentence Description:** Edoxaban (RXCUI 1599538), marketed as Savaysa, is indicated for the treatment of atrial fibrillation and pulmonary embolism, as shown by the provided MONDO and UMLS codes.\n\n3. **Summary:** Edoxaban is an anticoagulant used to treat cardiac and thromboembolic conditions.\n\n\n**Row 5:**\n\n1. **Column Names and Values:** `drug_labels`: TRABECTEDIN|YONDELIS; `drug_rxcui`: 1716278; `indications_label`: Ovarian cancer|Leiomyosarcoma; `indications_mondo`: MONDO:0008170|MONDO:0005058; `indications_umls`: C1140680|C0023269\n\n2. **Sentence Description:** Trabectedin (RXCUI 1716278), also known as Yondelis, is indicated for the treatment of ovarian cancer and leiomyosarcoma, with corresponding MONDO and UMLS codes.\n\n3. **Summary:** Trabectedin is an anti-cancer drug used in the treatment of specific types of cancers."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 27 describes the drug Chlor-Trimeton, also known as Chlorpheniramine or Chlorpheniramine Maleate, with RXCUI 2400, but lacks specified indications in the label, Mondo, or UMLS fields.  Row 25 details Abacavir (or Abacavir Sulfate, ZIAGEN), RXCUI 190521, indicated for HIV infection (MONDO:0005109, UMLS:C0019693). Row 29 lists Bromocriptine (or Bromocriptine Mesylate, Cycloset, Parlodel), RXCUI 1760, indicated for prolactinoma, Parkinson's disease, and prolactin-producing pituitary tumors (MONDO:0010911, MONDO:0005180, MONDO:0003430, UMLS:C0033375, C0030567, C0278863).  Row 28 refers to Carteolol (or OcuPress), RXCUI 2116, without listed indications.  Finally, Row 26 concerns Colistimethate, RXCUI 2708, also lacking specified indications.  In summary, the data shows varying levels of detail regarding drug indications, with some entries providing comprehensive information (including MONDO and UMLS identifiers) while others only list drug names and RXCUIs."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 30 describes the drug Adempas (RIOCIGUAT), with RXCUI 1439816, indicated for Pulmonary arterial hypertension, Pulmonary hypertension, and Cor pulmonale chronic, corresponding to MONDO:0015924, MONDO:0005149, MONDO:0001493, and UMLS C2973725, C0020542, C0238074 respectively.  This row indicates Adempas is used to treat various forms of pulmonary hypertension.\n\nRow 32 details the drug Generlac (LACTULOSE), RXCUI 6218, indicated for Constipation (MONDO:0002203 and UMLS C0009806), suggesting its use as a laxative.\n\nRow 33 shows that Diflucan (FLUCONAZOLE), RXCUI 4450, treats a range of fungal infections including Vulvovaginal candidiasis, Candida infection, Oral candidiasis, Oesophageal candidiasis, Coccidioidomycosis, Onychomycosis, and Urinary tract infection,  mapped to various MONDO and UMLS codes, indicating its broad-spectrum antifungal properties.\n\nRow 31 shows that Cedax (CEFTIBUTEN), RXCUI 20492, is indicated for Urinary tract infection (MONDO:0005247 and UMLS C0042029), suggesting its use as an antibiotic for urinary tract infections.\n\nRow 34 represents the drug Amidate (ETOMIDATE), RXCUI 4177, with no listed indications, MONDO codes, or UMLS codes, indicating a lack of provided information regarding its therapeutic uses."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 1 (ID: 37):**\n\nColumn names and values: `drug_labels` (ALISKIREN|TEKTURNA), `drug_rxcui` (325646), `indications_label` (Cardiovascular disorder|Cardiac failure|Hypertension), `indications_mondo` (MONDO:0004995|MONDO:0005252|MONDO:0005044), `indications_umls` (C0007222|C0018801|C0020538).\n\nSentence:  The drug Aliskiren (RXCUI 325646), also known as Tekturna, is indicated for the treatment of cardiovascular disorders, including cardiac failure and hypertension, as represented by the MONDO and UMLS codes provided.\n\nSummary: Aliskiren is a drug used to treat various cardiovascular conditions.\n\n\n**Row 2 (ID: 35):**\n\nColumn names and values: `drug_labels` (ETOPOPHOS|ETOPOSIDE|ETOPOSIDE INJECTION|ETOPOSIDE PHOSPHATE|ETOPOSIDE Teva|ETOPOSIDE.|TOPOSAR), `drug_rxcui` (4179), `indications_label` (Acute lymphocytic leukaemia|Small cell lung cancer|Hodgkin's disease|Acute myeloid leukaemia|Ewing's sarcoma|Lymphoma|Diffuse large B-cell lymphoma|Non-Hodgkin's lymphoma|Lung neoplasm malignant|Neuroblastoma|Testis cancer|Osteosarcoma|B-cell lymphoma|Gestational trophoblastic tumour|Germ cell cancer|Plasma cell myeloma|Testicular germ cell cancer), `indications_mondo` (MONDO:0013108|MONDO:0008433|MONDO:0009348|MONDO:0018874|MONDO:0012817|MONDO:0005062|MONDO:0018905|MONDO:0011508|MONDO:0008903|MONDO:0009741|MONDO:0010108|MONDO:0021054|MONDO:0004095|MONDO:0016784|MONDO:0006290|MONDO:0009693|MONDO:0003510), `indications_umls` (C0023449|C0149925|C0019829|C0023467|C0553580|C0024299|C0079744|C0024305|C0242379|C0027819|C0153594|C0029463|C0079731|C1135868|C0740345|C0026764|C0855197).\n\nSentence: Etoposide (RXCUI 4179), marketed under various names including Etopophos and Toposar, is a chemotherapy drug indicated for a wide range of cancers, such as various leukemias, lymphomas, lung cancer, and several other solid tumors, encompassing numerous MONDO and UMLS codes.\n\nSummary: Etoposide is a broad-spectrum cancer chemotherapy drug.\n\n\n**Row 3 (ID: 39):**\n\nColumn names and values: `drug_labels` (Relenza|ZANAMIVIR), `drug_rxcui` (69722), `indications_label` (Influenza|H1N1 influenza), `indications_mondo` (MONDO:0013855|MONDO:0005460), `indications_umls` (C0021400|C2076600).\n\nSentence: Zanamivir (RXCUI 69722), also known as Relenza, is an antiviral medication used to treat influenza, including the H1N1 strain, as indicated by the provided MONDO and UMLS codes.\n\nSummary: Zanamivir is an antiviral drug specifically targeting influenza.\n\n\n**Row 4 (ID: 38):**\n\nColumn names and values: `drug_labels` (ALCAINE|PROPARACAINE|PROPARACAINE HCL), `drug_rxcui` (34905), `indications_label` (), `indications_mondo` (), `indications_umls` ().\n\nSentence: Proparacaine (RXCUI 34905), also known as Alcaine, has no indications listed in this dataset.\n\nSummary: No indications are provided for Proparacaine in this dataset.\n\n\n**Row 5 (ID: 36):**\n\nColumn names and values: `drug_labels` (APTIVUS|TIPRANAVIR), `drug_rxcui` (190548), `indications_label` (), `indications_mondo` (), `indications_umls` ().\n\nSentence: Tipranavir (RXCUI 190548), also known as Aptivus, has no indications listed in this dataset.\n\nSummary: No indications are provided for Tipranavir in this dataset."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 40: The drug Ferric Carboxymaltose (INJECTAFER), with RxCUI 1433693, is indicated for iron deficiency anemia and anemia, corresponding to MONDO:0001356 and MONDO:0002280, and UMLS C0162316 and C0002871.  This row shows a drug used to treat iron deficiency anemia.\n\nRow 42:  The drug Dofetilide (DOFETILIDE, Tikosyn), with RxCUI 49247, treats atrial fibrillation, arrhythmia, cardiac disorder, and atrial flutter, aligning with MONDO:0004981, MONDO:0007263, MONDO:0005267, MONDO:0005310 and UMLS C0004238, C0003811, C0018799, C0004239. This row indicates a drug used for various cardiac rhythm problems.\n\nRow 41: The drug Degarelix (FIRMAGON), with RxCUI 475230, is indicated for prostate cancer, corresponding to MONDO:0008315 and UMLS C0376358. This row shows a drug specifically used in the treatment of prostate cancer.\n\nRow 44: The drug Amicar (Aminocarproic Acid), with RxCUI 99, has no listed indications, MONDO codes, or UMLS codes. This row lacks information on the drug's indications.\n\nRow 43: The drug Etoricoxib, with RxCUI 307296, has no listed indications, MONDO codes, or UMLS codes.  Similar to row 44, this row is missing crucial information regarding its indications for use."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 45 describes the drug Golimumab (Simponi), with RxNorm CUIs 819300, indicated for various arthritic conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthropathy, Crohn's disease, and psoriasis,  represented by both label text and Mondo and UMLS codes.  This indicates a broad range of autoimmune and inflammatory diseases as targets for this drug.\n\nRow 46 details Verteporfin (Visudyne), RxNorm CUI 118886, indicated for age-related and general macular degeneration, supported by label text and Mondo and UMLS codes.  This drug is specifically targeted at eye conditions.\n\nRow 47 shows 6-Mercaptopurine (Purixan), RxNorm CUI 103,  used to treat acute lymphocytic leukemia, Crohn's disease, and ulcerative colitis, using label text and Mondo and UMLS codes. This highlights its use in both cancers and inflammatory bowel diseases.\n\nRow 48 describes Tramadol (Ultracet), RxNorm CUI 352362, indicated for fibromyalgia, osteoarthritis, and arthritis, using label text and Mondo and UMLS codes.  This drug targets various pain conditions associated with musculoskeletal issues.\n\nRow 49 shows Midostaurin (Rydapt), RxNorm CUI 1919083, indicated for acute myeloid leukemia and systemic mastocytosis,  using label text and Mondo and UMLS codes.  This drug is used for specific types of blood cancers."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 51 describes panitumumab (Vectibix, RXCUI 263034), indicated for colon, colorectal, rectal, and rectosigmoid cancers, and adenocarcinoma of the colon (MONDO:0021063, MONDO:0005575, MONDO:0006519, MONDO:0002271, MONDO:0002424; UMLS: C0007102, C1527249, C0007113, C0338106, C1327709).  This indicates panitumumab's use in treating various forms of colorectal cancer.\n\nRow 53 details temazepam (Restoril, RXCUI 10355), used to treat insomnia and sleep disorders (MONDO:0013600, MONDO:0003406; UMLS: C0917801, C0851578), highlighting its role as a hypnotic medication.\n\nRow 52 shows sofosbuvir (Sovaldi, Vosevi, RXCUI 1484911), indicated for Hepatitis C, hepatic cirrhosis, and hepatitis (MONDO:0005231, MONDO:0005155, MONDO:0002251; UMLS: C0019196, C0023890, C0019158), demonstrating its use in treating liver diseases.\n\nRow 50 lists buprenorphine and buprenorphine/naloxone (Bunavail, Suboxone, Zubsolv, RXCUI 352364), indicated for drug dependence, abuse, withdrawal syndrome, and depression (MONDO:0005303, MONDO:0002491, MONDO:0004938, MONDO:0005567, MONDO:0002050; UMLS: C1510472, C0013146, C0439857, C0152128, C0011570), showcasing its use in opioid addiction treatment.\n\nRow 54 shows dexmethylphenidate (Focalin, RXCUI 352372) with no listed indications.  This suggests missing or incomplete data for this drug's approved uses."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 56:  The drug EDARBYCLOR (RxCUI 2409) is indicated for hypertension, represented by MONDO:0005044 and UMLS C0020538.  This row shows a single drug with a single indication for hypertension.\n\nRow 58:  FLUDARABINE (and its various forms, RxCUI 24698) is indicated for several types of leukemia and lymphoma, specifically chronic lymphocytic leukemia (MONDO:0004948, UMLS C0023434), acute myeloid leukemia (MONDO:0018874, UMLS C0023467), acute lymphocytic leukemia (MONDO:0013108, UMLS C0023449), B-cell lymphoma (MONDO:0004095, UMLS C0079731), and Non-Hodgkin's lymphoma (MONDO:0011508, UMLS C0024305). This row highlights the broad range of indications for this drug across different types of blood cancers.\n\nRow 57: The drug ATROPINE (and its various forms, RxCUI 594040) has no indications listed in this dataset.  This suggests that the provided data is incomplete for this drug.\n\nRow 55: The drug DIOVAN (VALSARTAN, RxCUI 69749) is indicated for hypertension (MONDO:0005044, UMLS C0020538), cardiac disorder (MONDO:0005267, UMLS C0018799), and cardiac failure (MONDO:0005252, UMLS C0018801). This row demonstrates that this drug is indicated for a range of cardiovascular conditions.\n\nRow 59: The drug METHOHEXITAL (RxCUI 6847) has no indications listed in this dataset. This indicates a lack of indication information for this drug within the provided data."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested.  Note that some rows lack indication information, making a full description challenging.\n\n**Row 64:**  This row contains data for drug RXCUI 20610, identified by brand names Cetirizine, Reactine, Zirtek, and Zyrtec.  Its labeled indications include hypersensitivity, seasonal allergy, urticaria, and several other allergic conditions,  corresponding to MONDO and UMLS codes indicating various allergic rhinitis, urticaria, and other hypersensitivity-related disorders.  This suggests that the drug Cetirizine is primarily used to treat a range of allergic reactions.\n\n**Row 61:** This row describes drug RXCUI 352381, including brand names Glipizide and Metformin, and various formulations thereof. Its labeled indications encompass Type 2 diabetes mellitus, other forms of diabetes, polycystic ovaries, and impaired glucose tolerance, linked to MONDO and UMLS codes for diabetic conditions and related metabolic disorders.  This indicates the drug's use in managing diabetes and related metabolic issues.\n\n**Row 60:** This row details drug RXCUI 49276, with brand names Cardura, Carduran, and Doxazosin.  Its labeled indications are hypertension and benign prostatic hyperplasia, with corresponding MONDO and UMLS codes confirming these conditions.  Therefore, this drug, Doxazosin, is used to treat high blood pressure and enlarged prostate.\n\n**Row 62:** This row presents drug RXCUI 10368 (Terbutaline) but lacks indication data in all provided fields (label, MONDO, UMLS).  Therefore, no detailed description or summary of its use is possible based on this data.\n\n**Row 63:** Similar to row 62, this row details drug RXCUI 2177 (Cefadroxil) but lacks indication data in all provided fields (label, MONDO, UMLS).  Therefore, no detailed description or summary of its use is possible based on this data."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 69 describes the drug Adefovir Dipivoxil (RXCUI: 16521), also known as Hepsera, indicated for treating Hepatitis B, including chronic Hepatitis B and hepatic cirrhosis (UMLS: C0019163, C0524909, C0023890; MONDO: 0005344, 0005366, 0005155).  Row 65 details Nortriptyline Hydrochloride (RXCUI: 7531), marketed as Pamelor, used to treat Depression (UMLS: C0011570; MONDO: 0002050). Row 66 shows Cefazolin (RXCUI: 2180), an antibiotic indicated for Staphylococcal infections (UMLS: C0038160; MONDO: 0024313). Row 68 refers to Pilocarpine (RXCUI: 8328), sold as Salagen, used to treat Glaucoma (UMLS: C0017601; MONDO: 0005041). Finally, row 67 indicates Abacavir/Lamivudine (RXCUI: 614534), marketed as Epzicom, for HIV infection (UMLS: C0019693; MONDO: 0005109).  The data shows a collection of drug information, linking drug names, RXCUIs, brand names, indications, and corresponding UMLS and MONDO identifiers."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 73 describes the drug Avonex (Interferon beta-1a), with RxNorm CUI 75917, indicated for multiple sclerosis (including relapsing-remitting, secondary progressive, and primary progressive forms), corresponding to MONDO IDs MONDO:0005301, MONDO:0005314, MONDO:0000450, MONDO:0000451 and UMLS CUI's C0026769, C0751967, C0751965, C0751964.  This indicates that Avonex is used to treat various forms of multiple sclerosis.\n\nRow 74 details the drug Lynparza (Olaparib), RxNorm CUI 1597582, indicated for ovarian, prostate, and breast cancers, and generally malignant neoplasms,  represented by MONDO IDs MONDO:0008170, MONDO:0008315, MONDO:0007254, MONDO:0004992 and UMLS CUIs C1140680, C0376358, C0006142, C0006826.  This shows Lynparza's application in treating several types of cancer.\n\nRow 70 shows the drug Cefotaxime (Cefotaxime sodium, Claforan), with RxNorm CUI 2186, but lacks specified indications, MONDO IDs, and UMLS CUIs.  Therefore, no indications are provided for this drug in this dataset.\n\nRow 72 describes the drug Avandia (Rosiglitazone), RxNorm CUI 84108, indicated for diabetes mellitus, specifically type 2, represented by MONDO ID MONDO:0015122 (listed twice) and UMLS CUIs C0011849 and C0011860.  This highlights Avandia's use in treating type 2 diabetes.\n\nRow 71 shows the drug Cefotetan, with RxNorm CUI 2187,  but similarly to row 70, lacks specified indications, MONDO IDs, and UMLS CUIs; thus, no indications are listed for this drug in this dataset."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 77:**  This row contains data for the drug Ceftriaxone (RXCUI: 2193),  indicated for treating pneumonia, urinary tract infection, bronchitis, osteomyelitis, Lyme disease, endocarditis, meningitis, and cellulitis, represented by MONDO and UMLS codes.  This suggests Ceftriaxone is a broad-spectrum antibiotic effective against a range of bacterial infections.\n\n**Row 76:** This row describes Obeticholic acid (OCALIVA, RXCUI: 1798288), indicated for primary biliary cirrhosis, biliary cirrhosis, cholangitis, and hepatic cirrhosis, with corresponding MONDO and UMLS codes. This indicates Obeticholic acid is used in the treatment of liver diseases.\n\n**Row 79:** This row shows information for Teriparatide (FORTEO, RXCUI: 32915), used to treat osteoporosis (including senile and postmenopausal types), bone disorders, pathological fractures, osteoarthritis, rheumatoid arthritis, and hypoparathyroidism, with associated MONDO and UMLS codes. This suggests Teriparatide is a medication for bone health and related conditions.\n\n**Row 75:** This row represents Ceftazidime (AVYCAZ, FORTAZ, RXCUI: 2191), but lacks indications, MONDO codes, and UMLS codes.  Therefore, no specific therapeutic uses can be determined from this incomplete data.\n\n**Row 78:** This row details Cefuroxime (CEFTIN, Zinacef, RXCUI: 2194), indicated for cellulitis, urinary tract infection, sinusitis, pneumonia, and bronchitis, with corresponding MONDO and UMLS codes.  This suggests Cefuroxime is an antibiotic used to treat various respiratory and skin infections."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested.  Note that the data is not in CSV format, but rather a series of key-value pairs.  I will interpret each block of key-value pairs as a single \"row\".\n\n**Row 1 (ID: 81):**  The drug Tetrabenazine (RXCUI: 10390), also known as Xenazine, is indicated for the treatment of Huntington's disease, chorea, tardive dyskinesia, Tourette's disorder, dystonia, tics, Meige's syndrome, torticollis, and other movement disorders (UMLS: C0020179, C0008489, C0686347, C0040517, C0013421, C0040188, C0025183, C0040485, C0026650; MONDO: MONDO:0007739, MONDO:0017645, MONDO:0010096, MONDO:0007661, MONDO:0003441, MONDO:0002420, MONDO:0007920, MONDO:0008583, MONDO:0005395).  This indicates a broad spectrum of neurological movement disorders are targeted by this medication.\n\n\n**Row 2 (ID: 80):** The drug Acebutolol (RXCUI: 149), also known as Sectral, has no listed indications in this dataset.  Further information is needed to determine its therapeutic uses.\n\n\n**Row 3 (ID: 84):**  Tetracycline (RXCUI: 10395), including its hydrochloride forms, is indicated for the treatment of acne (UMLS: C0702166; MONDO: MONDO:0011438). This shows a specific dermatological use for this antibiotic.\n\n\n**Row 4 (ID: 82):** Tetracaine (RXCUI: 10391) has no listed indications in this dataset.  Further information is needed to determine its therapeutic uses.\n\n\n**Row 5 (ID: 83):** Acenocoumarol (RXCUI: 154) has no listed indications in this dataset. Further information is needed to determine its therapeutic uses."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 87:  The drug with RXCUI 161, having brand names such as APAP, Tylenol, and Panadol, is indicated for Influenza and Nasopharyngitis, corresponding to MONDO IDs MONDO:0013855 and MONDO:0001040 and UMLS CUI's C0021400 and C0027441. This row shows a common over-the-counter analgesic used to treat viral respiratory infections.\n\nRow 88: The drug with RXCUI 10402, known as dronabinol (brand names Marinol and Syndros), has no indications listed in this dataset.  This suggests missing or incomplete data for this drug's approved uses.\n\nRow 85:  The drug dacarbazine (RXCUI 3098) is indicated for Hodgkin's disease, aligning with MONDO ID MONDO:0009348 and UMLS CUI C0019829. This row indicates a chemotherapeutic agent used in the treatment of Hodgkin Lymphoma.\n\nRow 89: The drug piroxicam (RXCUI 8356), also known as Feldene, has no indications listed in this dataset. This again suggests missing or incomplete data regarding its therapeutic uses.\n\nRow 86:  Penicillin V (RXCUI 7984), including its potassium salt forms, is indicated for tonsillitis, which maps to MONDO ID MONDO:0001039 and UMLS CUI C0040425. This row shows a common antibiotic used to treat bacterial tonsillitis."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 94:**  Row 94 shows that drug RXCUI 6313, with labels including Calcium Folinate and Leucovorin, is indicated for several cancers, specifically colorectal cancer, colon cancer, acute lymphocytic leukemia, adenocarcinoma of the colon, rectal cancer, and pancreatic carcinoma, as reflected in MONDO and UMLS codes.  This indicates that this drug is used in the treatment of various types of cancer.\n\n\n**Row 91:** Row 91 indicates that drug RXCUI 41126, encompassing various fluticasone formulations (like Flonase and Flovent), treats a wide range of hypersensitivity and respiratory conditions, including asthma, COPD, sinus disorders, rhinitis, bronchitis, and eosinophilic oesophagitis, supported by MONDO and UMLS codes. This suggests broad application in treating allergic and respiratory illnesses.\n\n\n**Row 93:** Row 93 shows that drug RXCUI 168, Acetic Acid, has no listed indications in the provided data, implying a lack of information or a different use case not captured here.  Further investigation is needed to determine its indications.\n\n\n**Row 90:** Row 90 shows that drug RXCUI 6854, Methoxsalen (UVAdex), is indicated for graft versus host disease, both chronic and acute forms, according to MONDO and UMLS codes. This drug is specifically used to treat complications arising from organ transplantation.\n\n\n**Row 92:** Row 92 shows that drug RXCUI 167, Acetazolamide (Diamox), has no listed indications in the provided data, similar to row 93.  Further information is required to understand its therapeutic applications."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 95 describes the drug ASTELIN/ASTEPRO (RXCUI 18603), indicated for allergic rhinitis, sinusitis, and seasonal allergies, with corresponding MONDO and UMLS codes provided.  Row 97 details ETHIODIZED OIL (RXCUI 4125) with no listed indications. Row 99 shows BUPIVACAINE (with various brand names; RXCUI 1815) lacking specified indications.  Rows 96 (CHOLECALCIFEROL, RXCUI 2418) and 98 (PANCREATIN, RXCUI 7880) similarly present drug names and RXCUIs but lack indication information.  In summary, the data shows incomplete information for several drugs, with only row 95 providing detailed indications for a specific medication."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 100:**  This row shows data for drug RXCUI 24947, identified as Ferrous Sulfate, with no listed indications in the label, MONDO, or UMLS fields.  Summary: This entry lacks indication information for Ferrous Sulfate.\n\n**Row 104:** This row contains data for drug RXCUI 88249, identified by various labels including Montelukast and Singulair,  indicating uses for asthma, allergic rhinitis, seasonal allergies, urticaria, chronic obstructive pulmonary disease, chronic spontaneous urticaria, and bronchitis, with corresponding MONDO and UMLS codes provided. Summary: Montelukast (Singulair) treats various respiratory and allergic conditions.\n\n**Row 102:** This row details RXCUI 2231, representing Cephalexin (Keflex), indicated for urinary tract infections and cellulitis, supported by MONDO and UMLS codes. Summary: Cephalexin is an antibiotic used to treat urinary tract infections and cellulitis.\n\n**Row 101:**  This row shows data for drug RXCUI 4278, identified as Famotidine (Pepcid), indicated for gastroesophageal reflux disease and dyspepsia, with associated MONDO and UMLS codes. Summary: Famotidine is used to treat gastrointestinal issues like GERD and dyspepsia.\n\n**Row 103:** This row represents RXCUI 41144, identified as Gadodamide,  but lacks indications in the label, MONDO, or UMLS fields. Summary:  This entry lacks indication information for Gadodamide."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 108:**  This row contains the drug Potassium Acetate, identified by RXCUI 54987, with drug labels listing \"POTASSIUM ACETATE\" and \"POTASSIUM ACETATE.\"  No indications are listed in the provided fields.  Summary:  The data describes Potassium Acetate but lacks information regarding its clinical indications.\n\n\n**Row 106:** This row details Thalidomide (RXCUI 10432), also known as Thalomid, indicated for a wide range of conditions including plasma cell myeloma, myelofibrosis, and various other cancers and inflammatory diseases, as listed by label, MONDO ontology terms, and UMLS CUI codes. Summary: Thalidomide has a broad range of indicated uses, spanning multiple disease categories and represented across various ontologies.\n\n\n**Row 107:** This row represents Alunbrig (Brigatinib, RXCUI 1921217), indicated for malignant lung neoplasms, as shown in the label, MONDO:0008903, and UMLS C0242379. Summary: Alunbrig is specifically indicated for the treatment of malignant lung tumors.\n\n\n**Row 105:** This row describes Eptifibatide (Integralin, RXCUI 75635), indicated for thrombosis and cerebral artery occlusion, supported by label, MONDO terms (MONDO:0000831 and MONDO:0000944), and UMLS codes (C0040053 and C0028790). Summary: Eptifibatide is used to treat blood clot related conditions, specifically thrombosis and cerebral artery occlusion.\n\n\n**Row 109:** This row contains information on Dalbavancin (Dalvance, RXCUI 1539239), indicated for cellulitis, as shown by label, MONDO:0005230, and UMLS C0007642. Summary: Dalbavancin is an antibiotic indicated for the treatment of cellulitis."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, following the requested format.  Note that the data is presented as a series of key-value pairs, not a CSV file as stated in the prompt.\n\n\n**Row 1 (ID: 113):**\n\nColumn Names and Values: `drug_labels` (CLOPIDOGREL, CLOPIDOGREL BISULFATE, PLAVIX), `drug_rxcui` (32968), `indications_label` (Acute coronary syndrome, Cerebrovascular accident, Myocardial infarction, Transient ischaemic attack, Coronary artery disease, Acute myocardial infarction, Atrial fibrillation, Myocardial ischaemia, Cerebral infarction, Thrombosis, Cardiac disorder, Ischaemic stroke, Arterial occlusive disease, Cardiovascular disorder, Angina unstable, Carotid artery stenosis, Peripheral vascular disorder, Hypertension, Arteriosclerosis, Coagulopathy), `indications_mondo` (MONDO:0005542, MONDO:0005098, MONDO:0005068, MONDO:0005264, MONDO:0005010, MONDO:0004781, MONDO:0004981, MONDO:0005010, MONDO:0002679, MONDO:0000831, MONDO:0005267, MONDO:0011057, MONDO:0005294, MONDO:0004995, MONDO:0006805, MONDO:0001612, MONDO:0005294, MONDO:0005044, MONDO:0002277, MONDO:0016627), `indications_umls` (C0948089, C0038454, C0027051, C0007787, C1956346, C0155626, C0004238, C0151744, C0007785, C0040053, C0018799, C0948008, C0003838, C0007222, C0002965, C0007282, C0085096, C0020538, C0003850, C0005779).  The drug Clopidogrel (RxCUI 32968), also known as Plavix, is indicated for a wide range of cardiovascular conditions, including acute coronary syndrome, stroke, and various forms of arterial disease, as evidenced by its extensive list of indications in both label and ontology terms.\n\n**Row 2 (ID: 110):**\n\nColumn Names and Values: `drug_labels` (Polystyrene Sulfonate), `drug_rxcui` (1546437), `indications_label` (), `indications_mondo` (), `indications_umls` (). The drug Polystyrene Sulfonate (RxCUI 1546437) has no indications listed in the provided data.\n\n**Row 3 (ID: 112):**\n\nColumn Names and Values: `drug_labels` (AZASITE, AZITHROMYCIN, AZITHROMYCIN 250 MG, Azithromycin 500 mg, Z-PAK, ZITHROMAX, Zitromax, Zmax), `drug_rxcui` (18631), `indications_label` (Pneumonia, Bronchitis, Sinusitis, Blepharitis, Nasopharyngitis, Ear infection, Influenza, Pharyngitis, Chlamydial infection, Mycobacterium avium complex infection, Bacterial infection, Eye infection, Obliterative bronchiolitis, Chronic obstructive pulmonary disease, Tonsillitis, Lung disorder), `indications_mondo` (MONDO:0005249, MONDO:0003781, MONDO:0005961, MONDO:0004785, MONDO:0001040, MONDO:0021666, MONDO:0013855, MONDO:0002258, MONDO:0005701, MONDO:0005866, MONDO:0015575, MONDO:0043885, MONDO:0005681, MONDO:0011751, MONDO:0001039, MONDO:0005275), `indications_umls` (C0032285, C0006277, C0037199, C0005741, C0027441, C0699744, C0021400, C0031350, C0008149, C0026916, C0004623, C0015403, C0006272, C0024117, C0040425, C0024115). Azithromycin (RxCUI 18631), sold under various brand names, treats a broad spectrum of bacterial infections, including respiratory tract infections (pneumonia, bronchitis, sinusitis), eye infections, and sexually transmitted infections (chlamydial infection).\n\n\n**Row 4 (ID: 114):**\n\nColumn Names and Values: `drug_labels` (LEVAQUIN, LEVOFLOXACIN, LEVOFLOXACIN 500 MG, LEVOFLOXACIN 750 MG, LEVOFLOXACIN ORAL SOLUTION), `drug_rxcui` (82122), `indications_label` (Pneumonia, Bacterial infection, Sinusitis, Bronchitis, Urinary tract infection, Diverticulitis, Tuberculosis, Prostatitis, Cystitis, Chronic obstructive pulmonary disease, Ear infection, Staphylococcal infection, Influenza, Cellulitis, Epididymitis, Kidney infection, Pulmonary tuberculosis, Nasopharyngitis, Pneumonitis, Asthma, Acute sinusitis, Pneumonia legionella, Pneumonia bacterial, Respiratory disorder, Chronic sinusitis, Pharyngitis), `indications_mondo` (MONDO:0005249, MONDO:0015575, MONDO:0005961, MONDO:0003781, MONDO:0005247, MONDO:0004235, MONDO:0018076, MONDO:0005280, MONDO:0006032, MONDO:0011751, MONDO:0021666, MONDO:0024313, MONDO:0013855, MONDO:0005230, MONDO:0004779, MONDO:0004369, MONDO:0006052, MONDO:0001040, MONDO:0043905, MONDO:0004979, MONDO:0005961, MONDO:0005824, MONDO:0004652, MONDO:0005087, MONDO:0006031, MONDO:0002258), `indications_umls` (C0032285, C0004623, C0037199, C0006277, C0042029, C0012813, C0041296, C0033581, C0010692, C0024117, C0699744, C0038160, C0021400, C0007642, C0014534, C0021313, C0041327, C0027441, C3714636, C0004096, C0149512, C0023241, C0004626, C0035204, C0149516, C0031350). Levofloxacin (RxCUI 82122), sold as Levaquin, is a fluoroquinolone antibiotic indicated for a wide array of bacterial infections affecting various body systems, including respiratory, urinary, and others.\n\n\n**Row 5 (ID: 111):**\n\nColumn Names and Values: `drug_labels` (ACTIRA, AVALOX, AVELOX, IZILOX, MOXEZA, moxifloxacin, MOXIFLOXACIN HCL, MOXIFLOXACIN HYDROCHLORIDE, VIGAMOX), `drug_rxcui` (139462), `indications_label` (Sinusitis, Pneumonia, Bronchitis, Tuberculosis, Conjunctivitis, Urinary tract infection, Chronic obstructive pulmonary disease, Eye infection), `indications_mondo` (MONDO:0005961, MONDO:0005249, MONDO:0003781, MONDO:0018076, MONDO:0003799, MONDO:0005247, MONDO:0011751, MONDO:0043885), `indications_umls` (C0037199, C0032285, C0006277, C0041296, C0009763, C0042029, C0024117, C0015403). Moxifloxacin (RxCUI 139462), marketed under various brand names, is another fluoroquinolone antibiotic used to treat bacterial infections, particularly respiratory infections and some eye infections."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 117 describes the drug Dasatinib (RxCUI 475342), also known as Sprycel, indicated for various leukemias (chronic myeloid, acute lymphocytic, acute myeloid, chronic lymphocytic) and other neoplasms including prostate cancer,  as reflected in its UMLS and MONDO codes.  Row 116 details the drug Glipizide (Glucotrol, RxCUI 4821) but lacks indication information. Row 115 concerns Ixekizumab (Taltz, RxCUI 1745099), indicated for psoriasis, psoriatic arthropathy, and rheumatoid arthritis, supported by MONDO and UMLS codes. Row 118 specifies Rifabutin (Ansatipine, Mycobutin, RxCUI 55672) for treating Mycobacterium avium complex infection, with corresponding MONDO and UMLS codes. Finally, Row 119 lists Thiabendazole (RxCUI 10450) but lacks indication details.  The data reveals that certain rows lack complete indication information, highlighting the incompleteness of the dataset."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 123:**  This row describes the drug Loratadine (also known as Alavert and Claritin), with RXCUI 28889, indicated for treating hypersensitivity, seasonal allergies, nasopharyngitis, urticaria, sinus disorders, rash, increased lacrimation, sinusitis, and allergic rhinitis, represented by various MONDO and UMLS codes.  This suggests Loratadine is a widely used antihistamine for a range of allergic conditions.\n\n\n**Row 124:** This row details Alteplase (also known as Activase), RXCUI 8410, indicated for ischemic stroke, cerebrovascular accident, acute myocardial infarction, pulmonary embolism, myocardial infarction, cerebral infarction, and cerebral artery occlusion, using corresponding MONDO and UMLS codes. This indicates Alteplase is a thrombolytic agent used to treat various thromboembolic conditions.\n\n\n**Row 122:** This row profiles Eszopiclone (also known as Lunesta), RXCUI 461016,  indicated for insomnia and sleep disorders, represented by MONDO and UMLS codes. This shows Eszopiclone is a medication for sleep-related issues.\n\n\n**Row 120:** This row shows Pegvisomant (also known as Somavert), RXCUI 278739, indicated for acromegaly, with a corresponding MONDO and UMLS code. This signifies Pegvisomant's use in treating acromegaly, a hormonal disorder.\n\n\n**Row 121:** This row presents Indacaterol (also known as Arcapta), RXCUI 1114326, indicated for chronic obstructive pulmonary disease and emphysema, using MONDO and UMLS codes. This suggests Indacaterol is a medication for respiratory conditions."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 1 (ID: 129):**  The drug Crisaborole (RXCUI 1865953), also known as Eucrisa, is indicated for the treatment of atopic dermatitis, eczema, dermatitis, psoriasis, and rash,  represented by MONDO codes MONDO:0011292, MONDO:0004980, MONDO:0002406, MONDO:0005083, and MONDO:0006547 and UMLS codes C0011615, C0013595, C0011603, C0033860, and C0015230.  This indicates a broad range of dermatological applications for this drug.\n\n**Row 2 (ID: 125):** The drug Felodipine (RXCUI 4316), marketed as Plendil, is used to treat hypertension,  represented by MONDO code MONDO:0005044 and UMLS code C0020538. This shows a specific cardiovascular indication for this medication.\n\n**Row 3 (ID: 128):** Daunorubicin (RXCUI 3109), available as Daunorubicin Hydrochloride, is indicated for the treatment of acute myeloid leukemia,  represented by MONDO code MONDO:0018874 and UMLS code C0023467. This highlights its use in oncology.\n\n**Row 4 (ID: 127):** The drug Lormetazepam (RXCUI 28894) has no indications listed in the provided data.  This suggests missing or incomplete information regarding its therapeutic applications.\n\n**Row 5 (ID: 126):** The drug Lorcaserin (RXCUI 1300701), also known as Belviq, is indicated for the treatment of obesity, represented by MONDO code MONDO:0011122 and UMLS code C0028754. This shows its use in managing weight-related conditions."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 131 lists drug labels FIASP, INSULIN ASPART, NOVOLOG, and NOVORAPID, with RXCUI 51428, indicating treatments for Type 2 diabetes mellitus, Type 1 diabetes mellitus, diabetes mellitus, gestational diabetes, and hyperglycemia, using MONDO and UMLS ontologies.  This row shows multiple insulin products used to treat various forms of diabetes.\n\nRow 132 shows drug labels AFTERA, FALLBACK SOLO, KYLEENA, LILETTA, MIRENA, MY WAY, NEXT CHOICE ONE DOSE, PLAN B ONE-STEP, Skyla, and TAKE ACTION, with RXCUI 6373, indicating treatments for endometriosis, uterine leiomyoma, adenomyosis, and endometrial hyperplasia, using MONDO and UMLS ontologies.  This row details various hormonal contraceptives and emergency contraceptives used to treat gynecological conditions.\n\nRow 130 lists drug labels DRONEDARONE and MULTAQ, with RXCUI 233698, indicating treatments for atrial fibrillation and arrhythmia, using MONDO and UMLS ontologies. This row indicates that dronedarone is used to treat cardiac arrhythmias.\n\nRow 133 lists drug labels TEPADINA, THIOTEPA, and THIOTEPA., with RXCUI 10473, indicating treatment for B-cell lymphoma using MONDO and UMLS ontologies. This row shows that thiotepa is a chemotherapy drug used to treat B-cell lymphoma.\n\nRow 134 lists the drug label levorphanol with RXCUI 6378, but lacks indications in the label, MONDO, or UMLS fields.  This row is incomplete and does not provide information on the drug's uses."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, formatted as requested.  Note that some rows have missing data, resulting in less comprehensive descriptions for those entries.\n\n\n**Row 138:**  This row details the drug with ID 4337, identified by the labels ABSTRAL, ACTIQ, etc., and which is associated with various indications including fibromyalgia, drug abuse, and several types of arthritis,  as represented by UMLS codes (C0016053, C0013146, etc.) and MONDO codes (MONDO:0005546, MONDO:0002491, etc.).  This suggests the drug is an opioid analgesic used to treat a wide range of pain conditions and potentially has a high risk for abuse.\n\n\n**Row 137:** This row describes the drugs DEFERIPRONE and FERRIPROX (RxCUI 11645), indicated for treating iron overload conditions like haemochromatosis, thalassaemia, and myelodysplastic syndrome, supported by UMLS codes (C0018995, C0039730, etc.) and MONDO codes (MONDO:0006507, MONDO:0000984, etc.).  The data indicates these drugs are used specifically to manage iron-related disorders.\n\n\n**Row 139:**  This row shows the drugs NAVELBINE, VINORELBINE, etc. (RxCUI 39541) are indicated for the treatment of breast cancer and various types of lung cancer, with corresponding MONDO codes (MONDO:0007254, MONDO:0008903, etc.) and UMLS codes (C0006142, C0242379, etc.). This suggests these are antineoplastic agents used in oncology.\n\n\n**Row 136:** This row contains information about RAMELTEON and ROZEREM (RxCUI 596205), indicated for the treatment of insomnia and sleep disorders, using MONDO codes (MONDO:0013600, MONDO:0003406) and UMLS codes (C0917801, C0851578). This identifies the drugs as hypnotics or sleep aids.\n\n\n**Row 135:** This row is incomplete, lacking drug indications, MONDO codes, and UMLS codes for the drug LOXOPROFEN (RxCUI 28908).  Therefore, no meaningful summary can be generated from this row alone."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 144:  The drug Acalabrutinib (CALQUENCE), with RXCUI 1986808, is indicated for Mantle cell lymphoma and Chronic lymphocytic leukaemia, corresponding to MONDO IDs MONDO:0018876 and MONDO:0004948 and UMLS CUI IDs C0334634 and C0023434 respectively.  This row shows a drug with specific indications for two types of lymphoma.\n\nRow 140: The drug entry for RXCUI 6387 lists multiple brand names (ASPERCREME WITH LIDOCAINE, EMLA, GLYDO, Lidocaine Injection, LIDODERM, ORAQIX, SOLARCAINE, XYLOCAINE, ZINGO) but lacks specified indications, MONDO IDs, and UMLS CUIs. This row highlights a drug with many brand names but missing crucial clinical information.\n\nRow 143: The drug KEVZARA (SARILUMAB), with RXCUI 1923319, is indicated for Rheumatoid arthritis, which corresponds to MONDO ID MONDO:0008383 and UMLS CUI C0003873. This row represents a drug specifically indicated for treating rheumatoid arthritis.\n\nRow 141: The drug Gemtuzumab ozogamicin (MYLOTARG), with RXCUI 1294580, is indicated for Acute myeloid leukaemia, corresponding to MONDO ID MONDO:0018874 and UMLS CUI C0023467. This row shows a drug specifically indicated for a type of leukemia.\n\nRow 142: The drug Thioguanine (TABLOID, TIOGUANINE), with RXCUI 10485, is indicated for Acute lymphocytic leukaemia, corresponding to MONDO ID MONDO:0013108 and UMLS CUI C0023449. This row shows a drug specifically indicated for another type of leukemia."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 148 shows that drug Captopril (RXCUI 1998) is indicated for hypertension (UMLS C0020538, MONDO:0005044).  Row 147 indicates that Micafungin (RXCUI 325887), also known as Mycamine, treats fungal infections, specifically Candida and Aspergillus infections (UMLS C0026946, C0006840, C0153252, C0004030; MONDO:0015578, MONDO:0002026, MONDO:0042233, MONDO:0005657).  Row 145 lists Dimethyl Sulfoxide (RXCUI 3455) with no listed indications. Row 146 shows that Roflumilast (Dalirep, RXCUI 1091836) is used to treat chronic obstructive pulmonary disease (UMLS C0024117, MONDO:0011751). Finally, Row 149 shows Thioridazine (RXCUI 10502) with no listed indications.  The data reveals that some drugs have clearly defined indications while others lack specified uses."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 1 (ID: 154):**  The drug Alirocumab (Praluent), with RXCUI 1659152, is indicated for the treatment of hyperlipidemia, including types IIa and V, and arteriosclerosis, as reflected by the MONDO codes MONDO:0013577, MONDO:0007750, MONDO:0007762, and MONDO:0002277, and UMLS codes C0020473, C0745103, C0020481, and C0003850.  This indicates that Alirocumab is used to treat various forms of high cholesterol and related cardiovascular conditions.\n\n**Row 2 (ID: 150):** Asenapine (Asenapine Maleate, Saphris), with RXCUI 784649, treats bipolar disorder, schizophrenia, depression, psychotic disorders, and schizoaffective disorder, corresponding to MONDO codes MONDO:0004985, MONDO:0005090, MONDO:0002050, MONDO:0005485, and MONDO:0005487, and UMLS codes C0005586, C0036341, C0011570, C0033975, and C0036337.  This shows Asenapine is an antipsychotic medication used for a range of mental health conditions.\n\n**Row 3 (ID: 153):** Condylox (Podofilox), with RXCUI 8463, lacks specified indications in the provided data fields for MONDO, UMLS, and labels.  Therefore, no conclusions about its use can be drawn from this data.\n\n**Row 4 (ID: 151):** The drug Zocor, with RXCUI 36567, is indicated for hyperlipidemia, aligning with the MONDO code MONDO:0013577 and the UMLS code C0020473. This suggests Zocor is a medication used to lower high cholesterol.\n\n**Row 5 (ID: 152):** Tivicay, with RXCUI 1433868, is indicated for HIV infection, as shown by the MONDO code MONDO:0005109 and the UMLS code C0019693. This clearly identifies Tivicay as an antiretroviral drug."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 1 (ID: 157):**  This row details the drug Aciclovir (also known as Sitavig and Zovirax), with RxNorm CUIs of 281, indicated for treating various herpes simplex and zoster infections, including encephalitis and varicella, represented by MONDO and UMLS codes for these conditions.  The summary is that this row profiles Aciclovir, a medication used to treat a range of viral infections caused by the herpes virus family.\n\n**Row 2 (ID: 155):** This row describes Mepolizumab (brand name Nucala), having RxNorm CUI 1720597, indicated for asthma and eosinophilic granulomatosis with polyangiitis,  as identified by MONDO and UMLS codes.  In summary, this row presents Mepolizumab, a drug targeted at specific inflammatory conditions, notably asthma and a rare vasculitis.\n\n**Row 3 (ID: 156):** This row shows Donepezil (brand names Aricept), with RxNorm CUI 135447, indicated for treating various types of dementia, including Alzheimer's disease, dementia with Lewy bodies, and vascular dementia, and related cognitive disorders, all specified by MONDO and UMLS identifiers.  The summary highlights Donepezil's use in managing cognitive decline associated with different forms of dementia.\n\n**Row 4 (ID: 159):**  This row details Pegloticase (brand name Krystexxa), with RxNorm CUI 1011650, indicated for the treatment of gout, as indicated by MONDO and UMLS codes.  In short, this row profiles Pegloticase as a medication specifically for gout.\n\n**Row 5 (ID: 158):** This row describes Zafirlukast (brand name Accolate), with RxNorm CUI 114970,  indicated for the treatment of asthma, with corresponding MONDO and UMLS codes. This row summarizes Zafirlukast as an asthma medication."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 1 (ID: 160):**  The drug Gemcitabine (RXCUI: 12574), also known as Gemzar, is indicated for a wide range of cancers including pancreatic, bladder, lung, and several types of lymphoma,  as evidenced by its numerous indications listed under various ontologies (UMLS, MONDO, and label-based indications).  This suggests Gemcitabine is a broadly applicable chemotherapeutic agent used in the treatment of various malignancies.\n\n**Row 2 (ID: 163):**  The drug Dyazide, containing Hydrochlorothiazide and Triamterene, (RXCUI: 258377) is indicated for the treatment of hypertension (UMLS: C0020538, MONDO:0005044), as stated on its label. This indicates its use in managing high blood pressure.\n\n**Row 3 (ID: 162):** The drug Evarrest, and others with the active ingredient thrombin (RXCUI: 10528), lacks specified indications in the provided data. Therefore, no summary statement can be made regarding its use.\n\n**Row 4 (ID: 164):** The drug Idelalisib (RXCUI: 1544460), marketed as Zydelig, treats various B-cell lymphomas including chronic lymphocytic leukemia,  non-Hodgkin's lymphoma, and mantle cell lymphoma (UMLS and MONDO codes provided). This highlights its targeted application in specific types of blood cancers.\n\n**Row 5 (ID: 161):** The drug Risedronic Acid (RXCUI: 55685) is indicated for the treatment of osteoporosis (UMLS: C0029456, MONDO:0005298), as shown on its label. This points to its use in managing bone density loss."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 169:**  The drug Chlorambucil (LEUKERAN), with RxCUI 2346, is indicated for Chronic lymphocytic leukemia, represented by MONDO:0004948 and UMLS C0023434.  This row shows a single drug indicated for a specific type of leukemia.\n\n**Row 167:** Abiraterone (ZYTIGA), RxCUI 1100072, treats Prostate cancer, Neoplasm malignant, and Bone cancer,  corresponding to MONDO:0008315, MONDO:0004992, MONDO:0002129, and UMLS C0376358, C0006826, C0279530 respectively. This indicates that Abiraterone is used to treat various types of cancer.\n\n**Row 168:** Acarbose (PRECOSE), with RxCUI 16681, is indicated for Type 2 diabetes mellitus (MONDO:0015122 and UMLS C0011860). This row shows a drug specifically indicated for a type 2 diabetes.\n\n**Row 165:**  Neupiro (Rotigotine), RxCUI 616739, treats Parkinson's disease and Restless legs syndrome, represented by MONDO:0005180, MONDO:0005391, and UMLS C0030567, C0035258 respectively. This row shows a drug with two distinct indications.\n\n**Row 166:**  Amitza (Lubiprostone), RxCUI 623033, is indicated for Constipation and Irritable bowel syndrome, corresponding to MONDO:0002203, MONDO:0005052, and UMLS C0009806, C0022104.  This row shows a drug indicated for gastrointestinal conditions."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, formatted as requested.  Note that the data is presented as a series of key-value pairs, not as a traditional CSV file with clearly delineated columns.  Therefore, the \"column names\" are the keys.\n\n**Row 173:**  The drug Lithium (RXCUI 6448) is indicated for Bipolar disorder, Depression, Schizoaffective disorder, and Schizophrenia, corresponding to MONDO IDs MONDO:0004985, MONDO:0002050, MONDO:0005487, and MONDO:0005090, and UMLS CUI IDs C0005586, C0011570, C0036337, and C0036341.  This indicates Lithium's use in treating various mental health disorders.\n\n**Row 171:** The drug Cosentyx (Secukinumab, RXCUI 1599788) is used to treat Psoriasis, Psoriatic arthropathy, Ankylosing spondylitis, and Rheumatoid arthritis, which map to MONDO IDs MONDO:0005083, MONDO:0011849, MONDO:0005306, and MONDO:0008383 and UMLS CUI IDs C0033860, C0003872, C0038013, and C0003873. This shows Cosentyx's application in treating autoimmune diseases affecting the skin and joints.\n\n**Row 172:** AmBisome (Liposomal Amphotericin B, RXCUI 236594) is indicated for various fungal infections including Mucormycosis, Aspergillus infection, Zygomycosis, Candida infection, Cryptococcosis, Visceral leishmaniasis, and Coccidioidomycosis, corresponding to MONDO IDs MONDO:0015578, MONDO:0019136, MONDO:0005657, MONDO:0019136, MONDO:0002026, MONDO:0005724, MONDO:0005445, and MONDO:0005706, and UMLS CUI IDs C0026946, C0026718, C0004030, C0043541, C0006840, C0010414, C0023290, and C0009186.  This highlights AmBisome's broad-spectrum antifungal activity.\n\n**Row 170:** Feraheme (Ferumoxytol, RXCUI 473387) treats Iron deficiency anaemia and Anaemia, aligning with MONDO IDs MONDO:0001356 and MONDO:0002280 and UMLS CUI IDs C0162316 and C0002871. This indicates Feraheme's role in managing iron deficiency.\n\n**Row 174:** Boceprevir (Victrelis, RXCUI 1102129) is indicated for Hepatitis C and Hepatic cirrhosis, which map to MONDO IDs MONDO:0005231 and MONDO:0005155 and UMLS CUI IDs C0019196 and C0023890. This showcases Boceprevir's use in treating liver diseases related to Hepatitis C."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 178:**  This row shows that the drug Odomzo (Sonidegib), with RXCUI 1659191, is indicated for Basal cell carcinoma, which corresponds to MONDO:0005341 and UMLS C0007117.  This indicates that Sonidegib is a medication used in the treatment of basal cell carcinoma.\n\n**Row 177:** This row details the drug Chlorhexidine (with various brand names including Hibiclens and Peridex), with RXCUI 2358, but lacks specified indications, MONDO codes, or UMLS codes.  This suggests that either the indications are not listed in this dataset or are missing.\n\n**Row 175:** The drug Betmiga (Mirabegron, Myrbetriq), RXCUI 1300786, is indicated for bladder disorders including interstitial cystitis and neurogenic bladder, aligning with MONDO codes MONDO:0006026, MONDO:0018301, MONDO:0001445 and UMLS codes C0005686, C0282488, C0005697.  This shows Mirabegron's use in treating various types of bladder dysfunction.\n\n**Row 179:** Balsalazide (Colzal), RXCUI 18747, is indicated for ulcerative colitis, corresponding to MONDO:0005101 and UMLS C0009324.  This highlights Balsalazide's role as a treatment for inflammatory bowel disease.\n\n**Row 176:**  This row lists Chlordiazepoxide (Librax), with RXCUI 2356, but lacks specified indications, MONDO codes, or UMLS codes. Similar to row 177, this suggests missing or incomplete data regarding the drug's indications."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 182 shows that the drug Alemtuzumab (also known as Campath and LEMTRADA), with RXCUI 117055, is indicated for Multiple sclerosis (relapsing-remitting), Chronic lymphocytic leukaemia, T-cell prolymphocytic leukaemia, and Mycosis fungoides, corresponding to MONDO IDs MONDO:0005301, MONDO:0005314, MONDO:0004948, MONDO:0019468, and MONDO:0009691, and UMLS CUI IDs C0026769, C0751967, C0023434, C2363142, and C0026948.  This indicates Alemtuzumab's use in treating both autoimmune and hematological cancers.\n\nRow 181 indicates that the drug Aciphex (Rabeprazole and Rabeprazole Sodium), with RXCUI 114979, treats Gastroesophageal reflux disease (GERD),  represented by MONDO:0007186 and UMLS C0017168.  This shows Aciphex is used specifically for the treatment of GERD.\n\n\nRow 183 shows that Azopt (Brinzolamide), with RXCUI 194881, is indicated for Glaucoma (including open-angle glaucoma) and Ocular hypertension,  corresponding to MONDO IDs MONDO:0005041, MONDO:0006875, and MONDO:0005338, and UMLS CUI IDs C0017601, C0028840, and C0017612. This highlights Azopt's role in managing eye pressure related conditions.\n\n\nRow 180 shows that Benzoyl Peroxide (also known as Proactiv and Proactiv Repairing Treatment), with RXCUI 1418, is indicated for treating Acne, represented by MONDO:0011438 and UMLS C0702166. This confirms Benzoyl Peroxide's common use as an acne treatment.\n\n\nRow 184 shows that Gleostine (Lomustine), with RXCUI 6466, is indicated for malignant brain neoplasms,  represented by MONDO:0001657 and UMLS C0153633.  This highlights Lomustine's use in oncology, specifically for brain cancers."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 187:  The drug, with labels \"Ativan,\" \"LORAZEPAM,\" \"LORAZEPAM 1 MG,\" and \"LORAZEPAM,\" has an RXCUI of 6470 and is indicated for Anxiety, Drug abuse, Insomnia, Depression, Sleep disorder, and Schizophrenia, corresponding to MONDO IDs MONDO:0011918, MONDO:0002491, MONDO:0013600, MONDO:0002050, MONDO:0003406, and MONDO:0005090, and UMLS IDs C0003467, C0013146, C0917801, C0011570, C0851578, and C0036341.  This shows that lorazepam is used to treat a wide range of psychiatric and sleep disorders.\n\nRow 188: The drug, with labels \"LOVASTATIN,\" \"LOVASTATIN.,\" and \"MEVACOR,\" has an RXCUI of 6472, but no listed indications, MONDO IDs, or UMLS IDs. This suggests that the provided data is incomplete for this drug's indications.\n\nRow 186: The drug, with labels \"AMERGE,\" \"Naratriptan,\" \"NARATRIPTAN HYDROCHLORIDE,\" and \"NARATRIPTAN HYDROCHLORIDE,\" has an RXCUI of 141366 and is indicated for Migraine, corresponding to MONDO ID MONDO:0008000 and UMLS ID C0149931. This indicates that naratriptan is specifically used to treat migraine headaches.\n\nRow 185: The drug, with labels \"IMODIUM,\" \"LOPERAMIDE,\" \"LOPERAMIDE HYDROCHLORIDE,\" and \"LOPERAMIDE HYDROCHLORIDE,\" has an RXCUI of 6468 and is indicated for Irritable bowel syndrome, Drug withdrawal syndrome, and Drug abuse, corresponding to MONDO IDs MONDO:0005052, MONDO:0005567, and MONDO:0002491, and UMLS IDs C0022104, C0152128, and C0013146.  This shows that loperamide treats gastrointestinal issues and is also relevant in managing drug withdrawal and abuse.\n\nRow 189: The drug, with label \"IBUTILIDE,\" has an RXCUI of 41289, but no listed indications, MONDO IDs, or UMLS IDs. This indicates missing information regarding the drug's indications."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n**Row 192:**  This row shows that the drug IRON SUCROSE (VENOFER), with RXCUI 24909, is indicated for Iron deficiency anaemia and Anaemia, corresponding to MONDO:0001356 and MONDO:0002280, and UMLS C0162316 and C0002871 respectively.  This indicates that the drug is used to treat various forms of anemia related to iron deficiency.\n\n**Row 194:** This row details that MACITENTAN (Opsumit), with RXCUI 1442132, treats Pulmonary arterial hypertension, Pulmonary hypertension, Cor pulmonale chronic, Portopulmonary hypertension, Pulmonary embolism, and Connective tissue disorder,  mapped to MONDO terms MONDO:0015924, MONDO:0005149, MONDO:0001493, MONDO:0017154, MONDO:0005279, MONDO:0003900 and UMLS C2973725, C0020542, C0238074, C1868851, C0034065, C0009782.  This highlights the drug's broad application in treating various forms of pulmonary hypertension and related conditions.\n\n**Row 193:**  The drug Arranon (Nelarabine), with RXCUI 274771, is indicated for T-cell type acute leukaemia, Precursor T-lymphoblastic lymphoma/leukaemia, and Acute lymphocytic leukaemia, linked to MONDO:0020512, MONDO:0003537, MONDO:0013108 and UMLS C1961099, C1301359, C0023449.  This shows that the drug is used specifically in the treatment of various types of leukemia involving T-cells.\n\n**Row 190:** The drug ADASUVE (LOXAPINE), with RXCUI 6475, has no listed indications, MONDO terms, or UMLS codes in this dataset. This suggests missing or incomplete information for this particular drug entry.\n\n**Row 191:**  ARMOUR THYROID, NATURE-THROID, NP THYROID, and THYROID (RXCUI 10572) are indicated for Hypothyroidism, which corresponds to MONDO:0015893 and UMLS C0020676. This indicates that these various thyroid medications are used to treat hypothyroidism."
    },
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, presented as requested:\n\n\n**Row 195:**  This row details the drug Levothyroxine (with various brand names including Levoxyl, Synthroid, etc.), having RXCUI 10582, indicated for treating hypothyroidism, thyroid disorders (such as autoimmune thyroiditis, thyroid cancer, and hyperthyroidism, including Basedow's disease), represented by Mondo IDs MONDO:0015893, MONDO:0015125, MONDO:0007699, MONDO:0002108, MONDO:0015894, MONDO:0010138 and UMLS CUI's C0020676, C0040128, C0920350, C0007115, C0020550, C0018213.  This suggests Levothyroxine is a widely used medication for various thyroid conditions.\n\n**Row 198:** This row describes the drug Flecainide (including Tambocor), with RXCUI 4441, indicated for treating atrial fibrillation and other arrhythmias (Mondo IDs MONDO:0004981, MONDO:0007263 and UMLS CUIs C0004238, C0003811). This indicates Flecainide's use in managing heart rhythm irregularities.\n\n\n**Row 196:** This row shows the drug Carmustine (including Bicnu and Gliadel), having RXCUI 2105,  indicated for treating malignant glioma and glioblastoma (Mondo IDs MONDO:0015917, MONDO:0018177 and UMLS CUIs C0555198, C0017636). This suggests Carmustine is a chemotherapy agent used specifically for brain cancers.\n\n\n**Row 197:** This row contains information about Polymyxin B (RXCUI 8536), but lacks indications, Mondo IDs, and UMLS CUIs.  Therefore, no specific indications for its use can be determined from this data.\n\n\n**Row 199:** This row shows the drug Barium (RXCUI 1311067) with no listed indications, Mondo IDs, or UMLS CUIs.  Consequently, the intended uses of this Barium formulation remain unknown based on this dataset."
    }
]